The list of research areas and treatments under analysis mentioned in various sources for Sarcoidosis includes:
Possibly curable or rare types of Sarcoidosis include:
Some rare types of Sarcoidosis include:
Treatments to consider for Sarcoidosis may include:
Biomarkers For Idiopathic Pulmonary fibrosis: Idiopathic Pulmonary Fibrosis (IPF) is a degenerative illness distinguished by progressive lung scarring and diminished breathing capacity, typically leading to death within about five years of diagnosis. There is no straightforward test for IPF as the lung is not highly accessible; biopsy procedures carry risk, and while imaging is good, it can't follow the disease biologically .Researchers analyzed the concentrations of 49 proteins in the plasma of 74 patients with IPF and 53 normal controls. A combination of five proteins related to normal tissue breakdown and remodeling and certain disease processes, including arthritis and cancer, was found to be highly indicative of IPF. Increases in two of the five, matrix metalloproteinases (MMP) 7 and 1, also were observed in tissue and fluid taken from the lungs of IPF patients. Other proteins in the IPF signature are matrix metalloproteinase 8, insulin-like growth factor binding protein 1 and tumor necrosis factor receptor super family member 1A . These proteins were increased in IPF patients, but not in patients with lung illnesses such as chronic obstructive pulmonary disease. Elevated MMP1 and MMP7 also distinguished IPF when compared to levels associated with another disease that closely mimics IPF, called sub acute/chronic hypersensitivity pneumonia. In particular, increased concentrations of MMP7 "may be indicative of asymptomatic lung disease and perhaps reflect disease progression. Elevated MMP1 and MMP7 also distinguished IPF when compared to levels associated with another disease that closely mimics IPF, called sub acute/chronic hypersensitivity pneumonia. In particular, increased concentrations of MMP7 "may be indicative of asymptomatic lung disease and perhaps reflect disease progression. The disease progresses very slowly. But a blood biomarker could indicate whether a drug is working earlier. The biomarkers also might be used for risk assessment and for evaluation of disease progression. Some known causes of pulmonary fibrosis include occupational and environmental exposure to asbestos, metal dust, farming chemicals and mold, an inflammatory disease called sarcoidosis, radiation, drug reactions, autoimmune disorders and possibly a genetic predisposition. Most cases are of unknown origin.
Some of the clinical trials for Sarcoidosis include:
What do you think about the features of this website? Take our user survey and have your say:
Next articles:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
Germs are a fact of life and catching an infectious disease like a cold may seem inevitable. But there are simple ways to protect yourself against...
Stress takes its toll by making us anxious, depressed and not able to function as fully as we'd like. What many don't know is that stress can...
Health insurance is important to everyone, especially people with chronic conditions like Crohn's disease and ulcerative colitis. Tune in to...
Sleep is necessary to feel refreshed, but now we know sleep actually impacts the way the body functions. Sleeping poorly can affect how often you get...